Product Description

RHBDD3 Polyclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: BS65979-50, BS65979-100

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Swiss-Prot: Q9Y3P4

Host: Rabbit

Reactivity: Human, Mouse, Rat,

Applications: WB

All Applications: WB=1:500-2000

Background: PTAG is a novel 386 amino acid multi-pass membrane protein that contains one UBA domain and augments drug-induced apoptosis. Cells lacking PTAG have a reduced apoptotic response, thereby causing a predisposition to cell malignancy and resistance to chemotherapeutic interventions, and PTAG plays a role in colorectal tumorigenesis as the majority of primary colorectal tumors lack the PTAG gene. Encoded by a gene located on human chromosome 22, PTAG is often co-expressed with EWS (ewing sarcoma breakpoint region 1), a gene located directly downstream of PTAG.

Purification and Purity: affinity purified by Protein A

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: RHBDD3 Polyclonal Antibody detects endogenous levels of RHBDD3 protein.

Bioworld Molecular Weight: 51 kD

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Primary: Anti- RHBDD3 at 1/1000 dilution

Alternative Name: C22orf3; HS984G1A; Pituitary tumor apoptosis; PTAG; RHBD3_HUMAN; RHBDD3; Rhomboid domain containing 3; Rhomboid domain-containing protein 3.

Immunogen: KLH conjugated synthetic peptide derived from human RHBDD3:151-250/386

Conjugate: Unconjugated

Modification: Unmodified